Income Statement Rix Corporation

Stocks

7525

JP3974500005

Industrial Machinery & Equipment

Delayed Japan Exchange Other stock markets 21:48:36 2026-07-28 EDT			5-day change	1st Jan Change
3,580.00 ^JPY	+0.14%		-0.56%	-3.77%

05-15	Rix Corporation Reports Earnings Results for the Full Year Ended March 31, 2026	CI
05-15	Rix Corporation Proposes Year-End Dividend for the Fiscal Year Ended March 31, 2026, Payable on June 26, 2026	CI

b371a384e142da2.DkQoo5VIqsIAgI-TWbVcZEhJX1kHomTH740rdJfrl2g.ayFB7dRw4bB4yNv2LdgYJyo8EAsy0TXxmexoPNOK-jtPF1_hpSvLo3Pf_A

Published financial data: RIX CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	39.97B	45.22B	49.75B	54.73B	55.83B
Total Revenues	39.97B	45.22B	49.75B	54.73B	55.83B
Cost of Goods Sold, Total	30.35B	33.74B	37.34B	41.14B	41.08B
Gross Profit	9.62B	11.49B	12.41B	13.59B	14.75B
Selling General & Admin Expenses, Total	6.76B	7.87B	8.55B	9.25B	10.21B
Provision for Bad Debts	-2M	-	-	7M	337M
R&D Expenses	56M	68M	70M	93M	89M
Depreciation & Amortization - (IS)	216M	226M	244M	364M	573M
Other Operating Expenses, Total	7.03B	8.16B	8.87B	9.71B	11.21B
Operating Income	2.58B	3.33B	3.54B	3.88B	3.54B
Interest Expense, Total	-3M	-5M	-4M	-10M	-13M
Interest And Investment Income	99M	119M	119M	161M	153M
Net Interest Expenses	96M	114M	115M	151M	140M
Income (Loss) On Equity Invest.	33M	32M	29M	33M	44M
Currency Exchange Gains (Loss)	195M	190M	164M	39M	51M
Other Non Operating Income (Expenses)	79M	84M	81M	91M	124M
EBT, Excl. Unusual Items	2.98B	3.75B	3.93B	4.2B	3.9B
Gain (Loss) On Sale Of Investments	3M	-	-2M	21M	-129M
Gain (Loss) On Sale Of Assets	1M	-	1M	8M	820M
Asset Writedown	-5M	-20M	-2M	-1M	-13M
Legal Settlements	-	-	-	-	-8M
Other Unusual Items	3M	2M	9M	-76M	19M
EBT, Incl. Unusual Items	2.99B	3.73B	3.94B	4.15B	4.59B
Income Tax Expense	908M	932M	1.12B	1.26B	1.5B
Earnings From Continuing Operations	2.08B	2.8B	2.82B	2.89B	3.08B
Net Income to Company	2.08B	2.8B	2.82B	2.89B	3.08B
Minority Interest	-28M	-33M	-41M	-48M	98M
Net Income - (IS)	2.05B	2.76B	2.78B	2.84B	3.18B
Net Income to Common Incl Extra Items	2.05B	2.76B	2.78B	2.84B	3.18B
Net Income to Common Excl. Extra Items	2.05B	2.76B	2.78B	2.84B	3.18B
Per Share Items
Net EPS - Basic	251.02	339.91	343.67	350.96	392.43
Basic EPS - Continuing Operations	251.02	339.91	343.67	350.96	392.43
Basic Weighted Average Shares Outstanding	8.17M	8.13M	8.09M	8.09M	8.1M
Net EPS - Diluted	251.02	339.91	343.67	350.96	392.43
Diluted EPS - Continuing Operations	251.02	339.91	343.67	350.96	392.43
Diluted Weighted Average Shares Outstanding	8.17M	8.13M	8.09M	8.09M	8.1M
Normalized Basic EPS	224.91	283.97	298.92	318.04	312.67
Normalized Diluted EPS	224.91	283.97	298.92	318.04	312.67
Dividend Per Share	65	-	141	141	157
Payout Ratio	21.89	26.49	45.05	35.34	38.68
Supplemental Items
EBITDA	2.93B	3.71B	3.96B	4.42B	4.35B
EBITA	2.58B	3.33B	3.54B	3.88B	3.54B
EBIT	2.58B	3.33B	3.54B	3.88B	3.54B
EBITDAR	3.53B	4.33B	4.64B	5.18B	5.23B
Effective Tax Rate - (Ratio)	30.4	25	28.41	30.35	32.8
Normalized Net Income	1.84B	2.31B	2.42B	2.57B	2.53B
Non-Cash Pension Expense	-18.04M	-15.63M	-16.33M	-134B	-13.28M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	156M	178M	172M	317M	336M
Net Rental Expense, Total	604M	625M	687M	761M	878M
Imputed Operating Lease Interest Expense	7.3M	13.16M	11.86M	33.29M	46.46M
Imputed Operating Lease Depreciation	597M	612M	675M	728M	832M

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	9.1B	8.7B	7.8B	8.18B	8.41B
Short Term Investments	100M	100M	100M	-	-
Total Cash And Short Term Investments	9.2B	8.8B	7.9B	8.18B	8.41B
Accounts Receivable, Total	15.33B	16.75B	18.93B	20.1B	20.82B
Notes Receivable	-	-	-	-	-
Total Receivables	15.33B	16.75B	18.93B	20.1B	20.82B
Inventory	2.38B	3.11B	3.41B	3.44B	3.83B
Prepaid Expenses	82M	91M	104M	124M	138M
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	192M	261M	304M	569M	580M
Total Current Assets	27.18B	29.01B	30.65B	32.41B	33.77B
Net Property Plant And Equipment	3.05B	3.61B	4.3B	5.42B	6.12B
Long-term Investments	3.21B	3.9B	4.9B	4.61B	5.41B
Other Intangibles, Total	163M	365M	733M	793M	1.63B
Loans Receivable Long-Term	408M	432M	527M	560M	543M
Deferred Tax Assets Long-Term	171M	126M	10M	13M	31M
Other Long-Term Assets, Total	1M	2M	1M	2M	1M
Total Assets	34.19B	37.44B	41.12B	43.81B	47.5B
Liabilities
Accounts Payable, Total	9.53B	10.64B	11.38B	12.14B	10.28B
Accrued Expenses, Total	853M	1.06B	1.07B	1.18B	1.32B
Short-term Borrowings	1.52B	1.4B	1.44B	1.41B	1.52B
Current Portion of Long-Term Debt	21M	21M	21M	21M	32M
Current Portion of Leases	20M	28M	34M	33M	43M
Current Income Taxes Payable	836M	604M	694M	862M	1.25B
Other Current Liabilities	479M	640M	791M	644M	1.76B
Total Current Liabilities	13.26B	14.4B	15.43B	16.28B	16.21B
Long-Term Debt	270M	248M	237M	205M	294M
Long-Term Leases	138M	134M	142M	115M	263M
Pension & Other Post Retirement Benefits	949M	759M	773M	825M	738M
Deferred Tax Liability Non Current	9M	30M	261M	171M	618M
Other Non Current Liabilities	65M	191M	200M	161M	197M
Total Liabilities	14.69B	15.76B	17.04B	17.76B	18.32B
Common Stock, Total	827M	827M	827M	827M	827M
Additional Paid In Capital	1.06B	1.07B	1.08B	1.1B	1.12B
Retained Earnings	16.99B	19.02B	20.54B	22.38B	24.53B
Treasury Stock	-407M	-609M	-601M	-591M	-582M
Comprehensive Income and Other	680M	975M	1.73B	1.78B	2.8B
Total Common Equity	19.14B	21.28B	23.58B	25.5B	28.7B
Minority Interest	356M	406M	489M	555M	490M
Total Equity	19.5B	21.68B	24.07B	26.05B	29.19B
Total Liabilities And Equity	34.19B	37.44B	41.12B	43.81B	47.5B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	8.17M	8.08M	8.09M	8.1M	8.11M
ECS Total Common Shares Outstanding	8.17M	-	8.09M	8.1M	8.11M
Book Value / Share	2.34K	2.63K	2.92K	3.15K	3.54K
Tangible Book Value	18.98B	20.91B	22.85B	24.7B	27.07B
Tangible Book Value Per Share	2.32K	2.59K	2.82K	3.05K	3.34K
Total Debt	1.96B	1.83B	1.87B	1.78B	2.15B
Net Debt	-7.24B	-6.96B	-6.03B	-6.39B	-6.26B
Debt Equivalent of Unfunded Proj. Benefit Obligation	504M	531M	455M	522M	194M
Debt Equivalent Oper. Leases	4.83B	5B	5.5B	6.09B	7.02B
Minority Interest, Total (Incl. Fin. Div)	356M	406M	489M	555M	490M
Inventories - Raw Materials, Total	196M	268M	244M	246M	309M
Inventories - Work In Process, Total	278M	330M	272M	622M	824M
Inventories - Finished Goods, Total	1.9B	2.51B	2.89B	2.57B	2.7B
Inventories - Others	1M	-	-	1M	1M
Full Time Employees	675	707	723	765	805
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	2M	6M
Order Backlog	5.1B	6.7B	7.61B	8.94B	12.94B

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	2.99B	3.73B	3.94B	4.15B	4.58B
Depreciation & Amortization - CF	345M	383M	413M	536M	815M
Depreciation & Amortization, Total	345M	383M	413M	536M	815M
(Gain) Loss From Sale Of Asset	4M	20M	1M	-7M	-806M
(Gain) Loss on Sale of Investments - (CF)	-2M	-	1M	-21M	130M
(Income) Loss On Equity Investments - (CF)	-33M	-32M	-29M	-33M	-44M
Other Operating Activities, Total	-578M	-1.18B	-1.01B	-1.16B	-1.52B
Change In Accounts Receivable	-1.57B	-1.38B	-2.14B	-1.12B	-608M
Change In Inventories	-642M	-711M	-271M	13M	-304M
Change In Accounts Payable	1.64B	1.05B	653M	639M	-1.53B
Change in Other Net Operating Assets	167M	253M	-67M	124M	621M
Cash from Operations	2.31B	2.13B	1.5B	3.13B	1.34B
Capital Expenditure	-278M	-943M	-968M	-1.63B	-1.04B
Sale of Property, Plant, and Equipment	2M	2M	1M	12M	915M
Cash Acquisitions	-65M	-123M	-50M	-	-
Sale (Purchase) of Intangible assets	-	-155M	-184M	-383M	-190M
Investment in Marketable and Equity Securities, Total	-318M	-232M	26M	-228M	-17M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-18M	16M	-61M	-25M	64M
Other Investing Activities, Total	-87M	-134M	-17M	-52M	-114M
Cash from Investing	-764M	-1.57B	-1.25B	-2.31B	-379M
Short Term Debt Issued, Total	18.61B	21.75B	19.16B	26.85B	22.9B
Long-Term Debt Issued, Total	-	-	20M	-	-
Total Debt Issued	18.61B	21.75B	19.18B	26.85B	22.9B
Short Term Debt Repaid, Total	-18.62B	-21.87B	-19.13B	-26.88B	-22.79B
Long-Term Debt Repaid, Total	-21M	-21M	-31M	-31M	-25M
Total Debt Repaid	-18.64B	-21.89B	-19.16B	-26.91B	-22.82B
Issuance of Common Stock	-	21M	22M	29M	23M
Repurchase of Common Stock	-	-210M	-	-	-
Common Dividends Paid	-449M	-732M	-1.25B	-1B	-1.23B
Common & Preferred Stock Dividends Paid	-449M	-732M	-1.25B	-1B	-1.23B
Other Financing Activities, Total	-23M	-23M	-27M	-33M	-59M
Cash from Financing	-496M	-1.08B	-1.24B	-1.07B	-1.19B
Foreign Exchange Rate Adjustments	103M	23M	51M	69M	129M
Miscellaneous Cash Flow Adjustments	-1M	-	1M	1M	279M
Net Change in Cash	1.15B	-501M	-941M	-183M	185M
Supplemental Items
Cash Interest Paid	3M	5M	4M	10M	13M
Cash Income Tax Paid (Refund)	579M	1.18B	1.01B	1.08B	1.52B
Levered Free Cash Flow	1.7B	372M	-67.5M	337M	456M
Unlevered Free Cash Flow	1.7B	375M	-65M	343M	464M
Change In Net Working Capital	-19M	989M	1.54B	602M	1.34B
Net Debt Issued / Repaid	-24M	-139M	21M	-62M	79M

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	5.01	5.8	5.64	5.71	4.84
Return on Total Capital	7.81	9.24	8.96	9.02	7.47
Return On Equity %	11.13	13.58	12.33	11.53	11.16
Return on Common Equity	11.18	13.67	12.39	11.58	11.74
Margin Analysis
Gross Profit Margin %	24.06	25.4	24.95	24.84	26.42
SG&A Margin	16.92	17.4	17.19	16.89	18.29
EBITDA Margin %	7.32	8.2	7.95	8.07	7.8
EBITA Margin %	6.46	7.35	7.12	7.09	6.34
EBIT Margin %	6.46	7.35	7.12	7.09	6.34
Income From Continuing Operations Margin %	5.2	6.18	5.67	5.28	5.52
Net Income Margin %	5.13	6.11	5.59	5.19	5.7
Net Avail. For Common Margin %	5.13	6.11	5.59	5.19	5.7
Normalized Net Income Margin	4.6	5.1	4.86	4.7	4.54
Levered Free Cash Flow Margin	4.25	0.82	-0.14	0.62	0.82
Unlevered Free Cash Flow Margin	4.25	0.83	-0.13	0.63	0.83
Asset Turnover
Asset Turnover	1.24	1.26	1.27	1.29	1.22
Fixed Assets Turnover	13.27	13.58	12.58	11.25	9.67
Receivables Turnover (Average Receivables)	2.75	2.82	2.79	2.8	2.73
Inventory Turnover (Average Inventory)	14.85	12.29	11.46	12.01	11.3
Short Term Liquidity
Current Ratio	2.05	2.01	1.99	1.99	2.08
Quick Ratio	1.85	1.77	1.74	1.74	1.8
Operating Cash Flow to Current Liabilities	0.17	0.15	0.1	0.19	0.08
Days Sales Outstanding (Average Receivables)	132.62	129.46	131.25	130.15	133.76
Days Outstanding Inventory (Average Inventory)	24.57	29.69	31.95	30.39	32.3
Average Days Payable Outstanding	103.08	106.81	107.08	104.28	98.67
Cash Conversion Cycle (Average Days)	54.12	52.34	56.12	56.27	67.39
Long Term Solvency
Total Debt/Equity	10.07	8.46	7.78	6.85	7.36
Total Debt / Total Capital	9.15	7.8	7.22	6.41	6.85
LT Debt/Equity	2.09	1.76	1.57	1.23	1.91
Long-Term Debt / Total Capital	1.9	1.62	1.46	1.15	1.78
Total Liabilities / Total Assets	42.96	42.09	41.45	40.54	38.56
EBIT / Interest Expense	860.67	665.2	886	388.2	272.15
EBITDA / Interest Expense	975.67	741.8	989.25	441.8	334.85
(EBITDA - Capex) / Interest Expense	883	553.2	747.25	278.4	255.08
Total Debt / EBITDA	0.67	0.49	0.47	0.4	0.49
Net Debt / EBITDA	-2.47	-1.88	-1.52	-1.45	-1.44
Total Debt / (EBITDA - Capex)	0.74	0.66	0.63	0.64	0.65
Net Debt / (EBITDA - Capex)	-2.73	-2.52	-2.02	-2.3	-1.89
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	10.95	13.15	10.01	10	2.01
Gross Profit, 1 Yr. Growth %	17.47	19.48	8.04	9.51	8.5
EBITDA, 1 Yr. Growth %	38.65	26.72	6.69	11.65	-1.47
EBITA, 1 Yr. Growth %	44.73	28.81	6.55	9.54	-8.86
EBIT, 1 Yr. Growth %	44.73	28.81	6.55	9.54	-8.86
Earnings From Cont. Operations, 1 Yr. Growth %	50.54	34.49	0.86	2.45	6.68
Net Income, 1 Yr. Growth %	50.37	34.71	0.58	2.23	11.93
Normalized Net Income, 1 Yr. Growth %	42.6	25.61	4.72	6.51	-1.59
Diluted EPS Before Extra, 1 Yr. Growth %	50.37	35.41	1.1	2.12	11.82
Accounts Receivable, 1 Yr. Growth %	11.74	9.29	13.01	6.16	3.58
Inventory, 1 Yr. Growth %	39.29	30.73	9.61	0.94	11.28
Net Property, Plant and Equip., 1 Yr. Growth %	2.52	18.39	19.11	26.13	12.81
Total Assets, 1 Yr. Growth %	13.28	9.52	9.82	6.56	8.43
Tangible Book Value, 1 Yr. Growth %	9.08	10.18	9.27	8.11	9.58
Common Equity, 1 Yr. Growth %	9.16	11.15	10.84	8.12	12.55
Cash From Operations, 1 Yr. Growth %	7.69	-7.88	-29.7	109.02	-57.05
Capital Expenditures, 1 Yr. Growth %	34.95	239.21	2.65	68.8	-36.54
Levered Free Cash Flow, 1 Yr. Growth %	-1.83	-78.11	-118.16	-599.26	35.35
Unlevered Free Cash Flow, 1 Yr. Growth %	-2.14	-77.95	-117.34	-628.08	35.25
Dividend Per Share, 1 Yr. Growth %	44.44	-	-	0	11.35
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-3.86	12.04	11.57	10.01	5.93
Gross Profit, 2 Yr. CAGR %	1.75	18.47	13.62	8.77	9
EBITDA, 2 Yr. CAGR %	0.64	32.55	16.27	9.14	4.88
EBITA, 2 Yr. CAGR %	0.1	36.54	17.16	8.04	-0.08
EBIT, 2 Yr. CAGR %	0.1	36.54	17.16	8.04	-0.08
Earnings From Cont. Operations, 2 Yr. CAGR %	6.12	42.29	16.47	1.65	4.54
Net Income, 2 Yr. CAGR %	5.98	42.33	16.4	1.4	6.97
Normalized Net Income, 2 Yr. CAGR %	4.61	33.84	14.69	5.61	2.38
Diluted EPS Before Extra, 2 Yr. CAGR %	5.98	42.69	17.01	1.61	6.86
Accounts Receivable, 2 Yr. CAGR %	-0.93	10.51	11.13	9.53	4.87
Inventory, 2 Yr. CAGR %	20.44	34.94	19.71	5.19	5.98
Net Property, Plant and Equip., 2 Yr. CAGR %	0.51	10.17	18.75	22.57	19.29
Total Assets, 2 Yr. CAGR %	6.18	11.39	9.67	8.17	7.49
Tangible Book Value, 2 Yr. CAGR %	9	9.63	9.72	8.69	8.85
Common Equity, 2 Yr. CAGR %	9.01	10.15	10.99	9.47	10.31
Cash From Operations, 2 Yr. CAGR %	0.55	-0.4	-19.53	21.22	-5.25
Capital Expenditures, 2 Yr. CAGR %	24.28	113.95	86.6	31.63	3.5
Levered Free Cash Flow, 2 Yr. CAGR %	-1.43	-53.65	-80.06	-4.77	159.95
Unlevered Free Cash Flow, 2 Yr. CAGR %	-1.55	-53.55	-80.44	-4.3	167.25
Dividend Per Share, 2 Yr. CAGR %	4.08	-	47.28	-	5.52
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-1.74	1.5	11.36	11.04	7.27
Gross Profit, 3 Yr. CAGR %	0.66	7.34	14.89	12.23	8.68
EBITDA, 3 Yr. CAGR %	-2.74	8.67	23.3	14.71	5.48
EBITA, 3 Yr. CAGR %	-3.36	8.88	25.71	14.56	2.08
EBIT, 3 Yr. CAGR %	-3.36	8.88	25.71	14.56	2.08
Earnings From Cont. Operations, 3 Yr. CAGR %	-0.85	14.84	26.87	11.59	3.3
Net Income, 3 Yr. CAGR %	-1.03	14.8	26.77	11.47	4.8
Normalized Net Income, 3 Yr. CAGR %	-0.53	11.18	23.33	11.9	3.15
Diluted EPS Before Extra, 3 Yr. CAGR %	-1.03	15	27.21	11.82	4.91
Accounts Receivable, 3 Yr. CAGR %	-1.86	2.37	11.33	9.45	7.51
Inventory, 3 Yr. CAGR %	5.67	23.78	25.91	13.09	7.18
Net Property, Plant and Equip., 3 Yr. CAGR %	-0.51	6.15	13.07	21.16	19.23
Total Assets, 3 Yr. CAGR %	4.12	7.28	10.86	8.62	8.26
Tangible Book Value, 3 Yr. CAGR %	8.04	9.39	9.51	9.18	8.99
Common Equity, 3 Yr. CAGR %	8.07	9.72	10.38	10.03	10.49
Cash From Operations, 3 Yr. CAGR %	7.9	-2.34	-11.32	10.62	-14.22
Capital Expenditures, 3 Yr. CAGR %	-13.53	73.68	67.5	80.47	3.22
Levered Free Cash Flow, 3 Yr. CAGR %	8.66	-40.31	-66.08	-41.67	7.07
Unlevered Free Cash Flow, 3 Yr. CAGR %	8.6	-40.21	-66.55	-41.33	7.4
Dividend Per Share, 3 Yr. CAGR %	0	-	46.33	29.45	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	3.43	3.32	3.38	4.82	9.16
Gross Profit, 5 Yr. CAGR %	5.82	6.35	5.65	7.91	12.5
EBITDA, 5 Yr. CAGR %	8.31	7.4	4.46	8.86	15.57
EBITA, 5 Yr. CAGR %	9.01	7.77	4.37	8.54	14.68
EBIT, 5 Yr. CAGR %	9.01	7.77	4.37	8.54	14.68
Earnings From Cont. Operations, 5 Yr. CAGR %	12.57	10.42	5.74	9.37	17.42
Net Income, 5 Yr. CAGR %	13.54	10.38	5.6	9.24	18.45
Normalized Net Income, 5 Yr. CAGR %	11.84	8.78	5.3	8.92	14.48
Diluted EPS Before Extra, 5 Yr. CAGR %	13.54	10.5	5.82	9.45	18.64
Accounts Receivable, 5 Yr. CAGR %	2.83	1.37	3.15	5.17	8.7
Inventory, 5 Yr. CAGR %	13.29	15.5	11.08	15.98	17.52
Net Property, Plant and Equip., 5 Yr. CAGR %	-0.02	4.3	6.79	12.44	15.52
Total Assets, 5 Yr. CAGR %	5.98	5.45	6.31	7.64	9.5
Tangible Book Value, 5 Yr. CAGR %	9.94	8.7	8.71	9.11	9.24
Common Equity, 5 Yr. CAGR %	9.91	8.87	9.23	9.62	10.35
Cash From Operations, 5 Yr. CAGR %	5.77	18.91	-4.04	6.48	-8.94
Capital Expenditures, 5 Yr. CAGR %	-13.38	26.42	17.62	55.45	38.16
Levered Free Cash Flow, 5 Yr. CAGR %	7.93	21.28	-44.85	-28.05	-23.4
Unlevered Free Cash Flow, 5 Yr. CAGR %	7.86	20.75	-45.3	-27.83	-23.19
Dividend Per Share, 5 Yr. CAGR %	13.84	-	16.75	18.64	28.39